French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy (ESGT)

Bernd Gänsbacher; Olivier Danos; George Dickson; Kris Thielemans; François Loic Cosset; Nicole Deglon; M. Sirac Dilber; Eithan Galun; David Klatzmann; Fulvio Mavilio; Naomi Taylor

doi:10.1002/jgm.364

French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy (ESGT)

Bernd Gänsbacher
, Olivier Danos
, George Dickson
, Kris Thielemans
, François Loic Cosset
, Nicole Deglon
, M. Sirac Dilber
, Eithan Galun
, David Klatzmann
, Fulvio Mavilio
, Naomi Taylor

Chair of Experimental Oncology and Therapy Research

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Original language	English
Pages (from-to)	82-84
Number of pages	3
Journal	Journal of Gene Medicine
Volume	5
Issue number	1
DOIs	https://doi.org/10.1002/jgm.364
State	Published - Jan 2003

Access to Document

10.1002/jgm.364

Cite this

Gänsbacher, B., Danos, O., Dickson, G., Thielemans, K., Cosset, F. L., Deglon, N., Dilber, M. S., Galun, E., Klatzmann, D., Mavilio, F., & Taylor, N. (2003). French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy (ESGT). Journal of Gene Medicine, 5(1), 82-84. https://doi.org/10.1002/jgm.364

@article{2dff186c4e624c2ca0805aa5071af16b,

title = "French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy (ESGT)",

author = "Bernd G{\"a}nsbacher and Olivier Danos and George Dickson and Kris Thielemans and Cosset, \{Fran{\c c}ois Loic\} and Nicole Deglon and Dilber, \{M. Sirac\} and Eithan Galun and David Klatzmann and Fulvio Mavilio and Naomi Taylor",

year = "2003",

month = jan,

doi = "10.1002/jgm.364",

language = "English",

volume = "5",

pages = "82--84",

journal = "Journal of Gene Medicine",

issn = "1099-498X",

publisher = "John Wiley and Sons Ltd",

number = "1",

}

Gänsbacher, B, Danos, O, Dickson, G, Thielemans, K, Cosset, FL, Deglon, N, Dilber, MS, Galun, E, Klatzmann, D, Mavilio, F & Taylor, N 2003, 'French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy (ESGT)', Journal of Gene Medicine, vol. 5, no. 1, pp. 82-84. https://doi.org/10.1002/jgm.364

French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy (ESGT). / Gänsbacher, Bernd; Danos, Olivier; Dickson, George et al.
In: Journal of Gene Medicine, Vol. 5, No. 1, 01.2003, p. 82-84.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy (ESGT)

AU - Gänsbacher, Bernd

AU - Danos, Olivier

AU - Dickson, George

AU - Thielemans, Kris

AU - Cosset, François Loic

AU - Deglon, Nicole

AU - Dilber, M. Sirac

AU - Galun, Eithan

AU - Klatzmann, David

AU - Mavilio, Fulvio

AU - Taylor, Naomi

PY - 2003/1

Y1 - 2003/1

UR - https://www.scopus.com/pages/publications/0037590036

U2 - 10.1002/jgm.364

DO - 10.1002/jgm.364

M3 - Article

C2 - 12516054

AN - SCOPUS:0037590036

SN - 1099-498X

VL - 5

SP - 82

EP - 84

JO - Journal of Gene Medicine

JF - Journal of Gene Medicine

IS - 1

ER -

French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy (ESGT)

Access to Document

Other files and links

Cite this